Drug formulation including ezetimiba and rosuvasttina

摘要

The present invention refers to a mixed pharmaceutical preparation containing ezetimiba and rosuvastina. The activity of this mixture is 0.40 or less. Comprehensive drug preparation may also include components selected from amlodipina, losartan and their combinations; ezetimiba exists in a physical state composed of rosuvasttina, amlodipina and losartan, respectively.